448 related articles for article (PubMed ID: 27244599)
1. Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer.
Pigna E; Berardi E; Aulino P; Rizzuto E; Zampieri S; Carraro U; Kern H; Merigliano S; Gruppo M; Mericskay M; Li Z; Rocchi M; Barone R; Macaluso F; Di Felice V; Adamo S; Coletti D; Moresi V
Sci Rep; 2016 May; 6():26991. PubMed ID: 27244599
[TBL] [Abstract][Full Text] [Related]
2. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
[TBL] [Abstract][Full Text] [Related]
3. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
4. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
[TBL] [Abstract][Full Text] [Related]
7. Combined Strategies for Maintaining Skeletal Muscle Mass and Function in Aging: Myostatin Inactivation and AICAR-Associated Oxidative Metabolism Induction.
Pauly M; Chabi B; Favier FB; Vanterpool F; Matecki S; Fouret G; Bonafos B; Vernus B; Feillet-Coudray C; Coudray C; Bonnieu A; Ramonatxo C
J Gerontol A Biol Sci Med Sci; 2015 Sep; 70(9):1077-87. PubMed ID: 25227129
[TBL] [Abstract][Full Text] [Related]
8. Combined Exercise Training Positively Affects Muscle Wasting in Tumor-Bearing Mice.
Ranjbar K; Ballarò R; Bover Q; Pin F; Beltrà M; Penna F; Costelli P
Med Sci Sports Exerc; 2019 Jul; 51(7):1387-1395. PubMed ID: 30724848
[TBL] [Abstract][Full Text] [Related]
9. Aerobic Exercise Ameliorates Cancer Cachexia-Induced Muscle Wasting through Adiponectin Signaling.
Morinaga M; Sako N; Isobe M; Lee-Hotta S; Sugiura H; Kametaka S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803685
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice.
Molinari F; Pin F; Gorini S; Chiandotto S; Pontecorvo L; Penna F; Rizzuto E; Pisu S; Musarò A; Costelli P; Rosano G; Ferraro E
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):954-973. PubMed ID: 29130633
[TBL] [Abstract][Full Text] [Related]
11. Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade.
Lautaoja JH; Lalowski M; Nissinen TA; Hentilä J; Shi Y; Ritvos O; Cheng S; Hulmi JJ
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E852-E865. PubMed ID: 30860875
[TBL] [Abstract][Full Text] [Related]
12. Aliskiren targets multiple systems to alleviate cancer cachexia.
Wang C; Guo D; Wang Q; You S; Qiao Z; Liu Y; Dai H; Tang H
Oncol Rep; 2016 Nov; 36(5):3014-3022. PubMed ID: 27667116
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of 25-hydroxy- and 1α,25-dihydroxy-vitamin D
Sustova H; De Feudis M; Reano S; Alves Teixeira M; Valle I; Zaggia I; Agosti E; Prodam F; Filigheddu N
Acta Physiol (Oxf); 2019 Jul; 226(3):e13269. PubMed ID: 30834670
[TBL] [Abstract][Full Text] [Related]
14. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
15. The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
Hall DT; Griss T; Ma JF; Sanchez BJ; Sadek J; Tremblay AMK; Mubaid S; Omer A; Ford RJ; Bedard N; Pause A; Wing SS; Di Marco S; Steinberg GR; Jones RG; Gallouzi IE
EMBO Mol Med; 2018 Jul; 10(7):. PubMed ID: 29844217
[TBL] [Abstract][Full Text] [Related]
16. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
Seto DN; Kandarian SC; Jackman RW
J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
[TBL] [Abstract][Full Text] [Related]
17. Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations.
Ballarò R; Beltrà M; De Lucia S; Pin F; Ranjbar K; Hulmi JJ; Costelli P; Penna F
FASEB J; 2019 Apr; 33(4):5482-5494. PubMed ID: 30653354
[TBL] [Abstract][Full Text] [Related]
18. Voluntary exercise does not improve muscular properties or functional capacity during C26-induced cancer cachexia in mice.
Hiroux C; Dalle S; Koppo K; Hespel P
J Muscle Res Cell Motil; 2021 Jun; 42(2):169-181. PubMed ID: 33606189
[TBL] [Abstract][Full Text] [Related]
19. Effect of exercise intensity and AICAR on isoform-specific expressions of murine skeletal muscle PGC-1α mRNA: a role of β₂-adrenergic receptor activation.
Tadaishi M; Miura S; Kai Y; Kawasaki E; Koshinaka K; Kawanaka K; Nagata J; Oishi Y; Ezaki O
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E341-9. PubMed ID: 21098736
[TBL] [Abstract][Full Text] [Related]
20. Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2/TRIP15/ALIEN.
Alves CRR; Neves WD; de Almeida NR; Eichelberger EJ; Jannig PR; Voltarelli VA; Tobias GC; Bechara LRG; de Paula Faria D; Alves MJN; Hagen L; Sharma A; Slupphaug G; Moreira JBN; Wisloff U; Hirshman MF; Negrão CE; de Castro G; Chammas R; Swoboda KJ; Ruas JL; Goodyear LJ; Brum PC
Mol Metab; 2020 Sep; 39():101012. PubMed ID: 32408015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
